Cancer and cancer survival modulates brain and behavior in a time-of-day-dependent manner in mice.
Animals
Anxiety
/ physiopathology
Biomarkers, Tumor
/ analysis
Brain
/ physiopathology
Cell Line, Tumor
Depression
/ physiopathology
Disease Models, Animal
Fatigue
/ physiopathology
Female
Habits
Humans
Inflammation
/ physiopathology
Mammary Neoplasms, Experimental
/ physiopathology
Mice, Inbred BALB C
Time Factors
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
24 04 2019
24 04 2019
Historique:
received:
17
01
2019
accepted:
10
04
2019
entrez:
26
4
2019
pubmed:
26
4
2019
medline:
21
10
2020
Statut:
epublish
Résumé
Improvements in breast cancer therapy/diagnosis have substantially increased the cancer survivor population, although many survivors report persistent mental health issues including fatigue, mood and anxiety disorders, and cognitive impairments. These behavioral symptoms impair quality-of-life and are often associated with increased inflammation. Nocturnal rodent models of cancer are critical to the identification of the neurobiological mechanisms underlying these behavioral changes. Although both behavior and immunity display distinct diurnal patterns, most rodent research in this field is performed during the rodents' inactive (light) period, which could potentially undermine the conclusions and clinical relevance. Therefore, here we tested the extent to which mammary tumors or tumor resection ("survivors") in mice affects behavior and neuroinflammation in a nyctohemeral (day versus night)-dependent manner. Indeed, only the dark (active) phase unmasked fatigue-like behavior and altered novel object investigation for both tumor-bearing and -resected mice relative to surgical controls. Several inflammatory markers were expressed in a time-of-day-dependent manner (lower in the dark phase) in the blood and brains of surgical control mice, whereas this temporal pattern was absent (IL-1β, CXCL1, Myd88, Cd4) or reversed (C3) in the respective tissues of tumor-bearing and -resected mice. Taken together, these data indicate that the time of day of assessment significantly modulates various persistent and transient tumor-induced behavioral and immune changes.
Identifiants
pubmed: 31019214
doi: 10.1038/s41598-019-42880-w
pii: 10.1038/s41598-019-42880-w
pmc: PMC6482139
doi:
Substances chimiques
Biomarkers, Tumor
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
6497Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR001070
Pays : United States
Références
Brain Behav Immun. 2014 Feb;36:147-55
pubmed: 24513875
Neurosci Biobehav Rev. 2002 Jan;26(1):91-104
pubmed: 11835987
Sci Transl Med. 2018 Sep 12;10(458):
pubmed: 30209245
Sci Rep. 2019 Jan 24;9(1):752
pubmed: 30679700
Genes Brain Behav. 2004 Jun;3(3):167-77
pubmed: 15140012
Mol Psychiatry. 2018 Jun;23(6):1421-1431
pubmed: 28373688
Physiol Behav. 2000 Jun 1-15;69(4-5):531-9
pubmed: 10913793
Proc Natl Acad Sci U S A. 2012 Jan 10;109(2):582-7
pubmed: 22184247
Biol Psychol. 2005 Apr;69(1):85-96
pubmed: 15740827
Nucleic Acids Res. 2013 Jan;41(Database issue):D1009-13
pubmed: 23180795
Clin Cancer Res. 2006 May 1;12(9):2759-66
pubmed: 16675568
Sci Rep. 2018 Aug 6;8(1):11720
pubmed: 30082828
Sci Rep. 2017 Aug 15;7(1):8152
pubmed: 28811490
Sci Rep. 2018 Jul 31;8(1):11474
pubmed: 30065253
Brain Behav Immun. 2015 Jan;43:76-85
pubmed: 25102452
Lab Anim. 2006 Oct;40(4):371-81
pubmed: 17018208
Clin Sci (Lond). 2011 Nov;121(9):367-87
pubmed: 21745188
Immunity. 2012 Feb 24;36(2):251-61
pubmed: 22342842
Immunity. 2014 Feb 20;40(2):178-86
pubmed: 24560196
Int J Cancer. 2016 Dec 15;139(12):2635-2645
pubmed: 27367824
J Immunol. 2010 Nov 15;185(10):5796-805
pubmed: 20944004
Hum Brain Mapp. 2011 Aug;32(8):1206-19
pubmed: 20669165
Nature. 2007 Mar 1;446(7131):41-5
pubmed: 17287729
Behav Sci (Basel). 2018 Jan 18;8(1):
pubmed: 29346276
Cell. 2002 Jul 26;110(2):251-60
pubmed: 12150932
Physiol Behav. 1996 Jan;59(1):45-7
pubmed: 8848489
Brain Behav Immun. 2013 Mar;30 Suppl:S126-34
pubmed: 22884960
Behav Brain Res. 2014 Oct 1;272:83-92
pubmed: 24995613
Biol Pharm Bull. 2007 Apr;30(4):621-6
pubmed: 17409491
Brain Behav Immun. 2007 Mar;21(3):251-8
pubmed: 17008048
Brain Behav Immun. 2015 Oct;49:1-17
pubmed: 25958011
Behav Pharmacol. 2010 May;21(3):231-40
pubmed: 20480545
Cancer Res. 1978 Oct;38(10):3174-81
pubmed: 210930
Immunity. 2019 Feb 19;50(2):317-333.e6
pubmed: 30683620
Brain Res. 2019 Mar 15;1707:133-140
pubmed: 30496733
Psychoneuroendocrinology. 2017 May;79:59-66
pubmed: 28259044
PLoS One. 2012;7(10):e48414
pubmed: 23119008
Dev Neurosci. 2015;37(6):497-514
pubmed: 26184807
Brain Behav Immun. 2013 Mar;30 Suppl:S48-57
pubmed: 22776268
J Cereb Blood Flow Metab. 2019 Nov;39(11):2268-2276
pubmed: 30092705
Physiol Behav. 1998 Feb 15;63(4):577-85
pubmed: 9523901
Life Sci. 2015 Dec 15;143:65-70
pubmed: 26498217
Brain Behav Immun. 2013 Nov;34:159-63
pubmed: 24012645
Proc Natl Acad Sci U S A. 2009 Dec 15;106(50):21407-12
pubmed: 19955445
Cell. 2002 May 3;109(3):307-20
pubmed: 12015981
Brain Behav Immun. 2011 Mar;25(3):555-64
pubmed: 21182930
Genome Biol. 2007;8(11):R247
pubmed: 18028544
Proc Natl Acad Sci U S A. 2009 Jun 2;106(22):9069-74
pubmed: 19451634
Int Anesthesiol Clin. 2007 Spring;45(2):27-37
pubmed: 17426506
PLoS Comput Biol. 2008 Oct;4(10):e1000193
pubmed: 18846204
Nat Rev Neurosci. 2018 Oct;19(10):622-635
pubmed: 30206328
Clin J Oncol Nurs. 2008 Oct;12(5 Suppl):11-20
pubmed: 18842520
Front Immunol. 2017 Sep 04;8:1075
pubmed: 28928743
Behav Brain Res. 2017 Jul 14;330:108-117
pubmed: 28479263
Brain Res. 2014 Mar 13;1552:55-63
pubmed: 24457042
Brain Behav Immun. 2013 Mar;30 Suppl:S19-25
pubmed: 22728325
Cancer Res. 1992 Mar 15;52(6):1399-405
pubmed: 1540948
Brain Behav Immun. 2015 Mar;45:171-9
pubmed: 25433170
Brain Res Bull. 2012 Oct 1;89(1-2):50-6
pubmed: 22796103
Brain Behav Immun. 2010 Aug;24(6):903-7
pubmed: 20188817
Cancer Growth Metastasis. 2015 Jul 23;8:25-34
pubmed: 26279628